The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Principles of laboratory assessment of drug abuse liability and implications for clinical development
Open accessAbstract
Abuse liability testing plays an important role in informing drug development, regulatory processes, and clinical practice. This paper describes the current “gold standard” methodologies that are used for laboratory assessments of abuse liability in non-human and human subjects. Particular emphasis is given to procedures such as non-human drug discrimination, self-administration, and physical dependence testing, and human dose effect abuse liability studies that are commonly used in regulatory submissions to governmental agencies. The potential benefits and risks associated with the inclusion of measures of abuse liability in industry-sponsored clinical trials is discussed. Lastly, it is noted that many factors contribute to patterns of drug abuse and dependence outside of the laboratory setting and positive or negative signals in abuse liability studies do not always translate to high or low levels of actual abuse or dependence. Well-designed patient and physician education, pharmacovigilance, and postmarketing surveillance can reduce the diversion and misuse of drugs with abuse liability and can effectively foster the protection and promotion of public health.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Self‐administration of drugs in animals and humans as a model and an investigative tool
Panlilio, L. V., & Goldberg, S. R. (2007) · Addiction · doi:10.1111/j.1360-0443.2007.02011.x · Cited by 322
Acute administration of buprenorphine in humans: partial agonist and blockade effects.
Walsh, S. L., Preston, K. L., Bigelow, G. E., & Stitzer, M. L. (1995) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10510-7 · Cited by 283
Controversies in translational research: drug self-administration.
Haney, M., & Spealman, R. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1079-x · Cited by 270
Griffiths, R. R., & Weerts, E. M. (1997) · Psychopharmacology · doi:10.1007/s002130050422 · Cited by 260
Self-citationREPLACING RELATIVE REINFORCING EFFICACY WITH BEHAVIORAL ECONOMIC DEMAND CURVES
Johnson, M. W., & Bickel, W. K. (2006) · Journal of the Experimental Analysis of Behavior · doi:10.1901/jeab.2006.102-04 · Cited by 187 · cited 2×
“An approach that has been proposed as an alternative to the traditional measures associated with relative reinforcing efficacy is the examination of the elasticity of demand that is derived from behavioral economic studies (Bickel et al., 2000; Johnson and Bickel, 2006).”
BackgroundNegus, S. S., & Rice, K. C. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.127 · Cited by 70 · cited 2×
“…serve as an important negative reinforcement mechanism for the self-administration of some drugs, examination of how the reinforcing effects of a drug might change under conditions of withdrawal might be a valuable additional component of abuse liability assessment (e.g., Negus and Rice, 2009).”
BackgroundAlprazolam absorption kinetics affects abuse liability
Mumford, G. K., Evans, S. M., Fleishaker, J. C., & Griffiths, R. R. (1995) · Clinical Pharmacology & Therapeutics · doi:10.1016/0009-9236(95)90162-0 · Cited by 63
Cited by
Johnson, M. W., Griffiths, R. R., Hendricks, P. S., & Henningfield, J. E. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.05.012 · Cited by 354
“The methods developed have continued to be refined over the past half century and remain the foundation for human abuse potential assessment studies (Carter and Griffiths, 2009; Griffiths et al., 2003; U.S. Food and Drug Administration, 2017a).”
Self-citationElectronic Cigarettes: Effective Nicotine Delivery After Acute Administration
Vansickel, A. R., & Eissenberg, T. (2013) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntr316 · Cited by 346
Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability
Bonaventura, J., Lam, S., Carlton, M., Boehm, M. A., Gomez, J. L., Solís, O., Sánchez-Soto, M., Morris, P. J., Fredriksson, I., Thomas, C. J., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01093-2 · Cited by 271
Howell, L. L., & Cunningham, K. A. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.009514 · Cited by 262
Abuse Liability Assessment of Tobacco Products Including Potential Reduced Exposure Products
Carter, L. P., Stitzer, M. L., Henningfield, J. E., O'Connor, R. J., Cummings, K. M., & Hatsukami, D. K. (2009) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0948 · Cited by 186
Self-citation
Metadata
- Authors
- Carter, L. P., & Griffiths, R. R.
- Venue
- Drug and Alcohol Dependence
- Publisher
- Elsevier BV
- Published
- 2009-12
- Volume
- 105
- Pages
- S14-S25
- ISSN
- 0376-8716 (ISSN-L)
- OpenAlex
- W2004030834
- Cited by
- 211
- References
- 7
- FWCI
- 10.69
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Principles of laboratory assessment of drug abuse liability and implications for clinical development. https://app.cochat.ai/papers/10.1016/j.drugalcdep.2009.04.003
- The paper
- Carter, L. P., & Griffiths, R. R. (2009). Principles of laboratory assessment of drug abuse liability and implications for clinical development. Drug and Alcohol Dependence. https://doi.org/10.1016/j.drugalcdep.2009.04.003
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.